Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Kia EV9 GT marks world debut at LA Motor Show
-
9
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
10
S. Korea not to attend Sado mine memorial: foreign ministry
[DISCLOSURE] Hanmi Pharmaceutical (128940) and its affiliate Hanmi Science (008930) have sold all of their shares of Crystal Genomics (083790), the companies announced on June 15. They owned 1.48 million shares of the drug developer or a 14.34 percent stake.
